Urology News and Research

Latest Urology News and Research

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus compared to fully boosted heart failure patients, according to new research out of Mount Sinai Heart.

9 Jun 2022

Hospice patients with dementia more likely to receive excellent care, study shows

While the hospice program was originally designed for patients with cancer, who are expected to die within six months, currently close to half of older adult hospice enrollees have a diagnosis of dementia.

6 Jun 2022

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.

3 Jun 2022

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia.

1 Jun 2022

Study shows how stress has a major impact on the immune system's ability to fight infections

Acute stress can be detrimental to fighting off infection, especially COVID-19, and increases the chance of dying in mouse models.

30 May 2022

Patient’s perspective on their physical well-being can help better predict cancer treatment outcomes

A breast cancer patient’s perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools, a new study has found, highlighting the importance of shared decision-making in the treatment process.

26 May 2022

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

The accelerated advancement of cancer immunology and immunotherapy, a type of biological therapy that boosts the immune system's ability to recognize and kill cancer cells, has significantly improved the effectiveness of cancer treatment and patient outcomes.

25 May 2022

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers found.

25 May 2022

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.

23 May 2022

COVID-19's impact on sex and fertility

The potential effects of SARS-CoV-2 on sexual activity and fertility.

20 May 2022

Standard blood cancer test holds clear clues of rare IgD multiple myeloma

A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.

19 May 2022

Developing innovative approaches to combat urinary tract infections

The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg.

18 May 2022

Robotic surgery reduces readmissions, benefits patients' overall recovery

A new study, published in JAMA, has found that robotic surgery reduces the chance of readmission by half (52 per cent), and revealed a "striking" four-fold (77 per cent) reduction in prevalence of blood clots (deep vein thrombus and pulmonary emboli) - a significant cause of health decline and morbidity - when compared to patients who had open surgery.

15 May 2022

Immunotherapy after bladder cancer surgery helps reduce cancer recurrence

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, according to clinical trial results presented at the American Urological Association annual meeting in May.

15 May 2022

Researchers discover new gene that confers resistance to prostate cancer treatment

Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.

13 May 2022

Penn study finds low uptake of first mutation-targeted bladder cancer drug

The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

12 May 2022

CMR Surgical; Transforming Surgery through Robotics

In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius.

From CMR Surgical 12 May 2022

Study shows effectiveness of point-of-care smoking cessation program for cancer patients

New research in the May 2022 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds the inclusion of the smoking cessation tool Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE, from Epic) into electronic health records (EHRs) can increase self-reported patient quit rates by more than 5 percentage points.

11 May 2022

Study modeling tumor evolution reveals a central tradeoff that could be exploited for cancer treatment

Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors.

11 May 2022

Henry Ford Health offers a non-surgical treatment option for localized prostate cancer

Henry Ford Health is the first in Michigan to offer Robotic High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer. This non-surgical treatment option spares surrounding healthy tissue, while allowing for a quicker treatment time and recovery for the patient.

10 May 2022

Urology News and Research

Latest Urology News and Research

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

Hospice patients with dementia more likely to receive excellent care, study shows

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Study shows how stress has a major impact on the immune system's ability to fight infections

Patient’s perspective on their physical well-being can help better predict cancer treatment outcomes

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

COVID-19's impact on sex and fertility

Standard blood cancer test holds clear clues of rare IgD multiple myeloma

Developing innovative approaches to combat urinary tract infections

Robotic surgery reduces readmissions, benefits patients' overall recovery

Immunotherapy after bladder cancer surgery helps reduce cancer recurrence

Researchers discover new gene that confers resistance to prostate cancer treatment

Penn study finds low uptake of first mutation-targeted bladder cancer drug

CMR Surgical; Transforming Surgery through Robotics

Study shows effectiveness of point-of-care smoking cessation program for cancer patients

Study modeling tumor evolution reveals a central tradeoff that could be exploited for cancer treatment

Henry Ford Health offers a non-surgical treatment option for localized prostate cancer

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Urology News and Research

Latest Urology News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in